Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new roof extension was awarded the 2021 Green Award for Sustainability by the Oxford Preservation Trust alongside a Certificate in the New Building category.

The front entrance to the Kennedy Institute

The Kennedy Institute of Rheumatology was delighted to receive two awards from the Oxford Preservation Trust, which celebrates the contribution that buildings and environmental projects make to the city’s character. The new roof extension won the 2021 Green Award for Sustainability as well as being awarded a Certificate in the New Building category.

It was designed by Fathom Architects to target ambitious PassivHaus EnerPHit standards and included designing for airtightness, minimizing thermal bridging and the use of triple glazing.

One of the key considerations was the energy efficiency of the building. To minimise the impact of cooling, glazing was replaced by fixed panels, external louvres and internal blinds. Insulation was added behind the non-transparent parts of the wall to improve its thermal performance. The roof has also been future-proofed with the structure designed to accommodate photo voltaic panels to be installed at a later stage.

The features were incorporated while maintaining the aesthetic of the original building.

Chairman of the Awards Panel, The Rev Prof William Whyte remarked that the sustainability standards reached were an “extraordinarily difficult thing to do with laboratories.”

Read more about the new roof extension.

Similar stories

Welcome to the new Kennedy Trust CEO

The Kennedy Trust has announced Dr Stephen Simpson as its new Chief Executive Officer from 1 July 2022.

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Professor Chris Buckley joins the Kennedy Institute as Director of Clinical Research

Moving to the University of Oxford with the Arthritis Therapy Acceleration Programme (A-TAP) will help accelerate the discovery of new treatments for inflammatory diseases.

New Oxford-Zeiss Centre of Excellence opens at the University of Oxford

The Kennedy Institute for Rheumatology and the Institute of Developmental and Regenerative Medicine announce the launch of the Oxford-Zeiss Centre of Excellence, providing state-of-the-art imaging technologies to lead future discoveries in global health and disease.